A kind of preparation method of human coagulation factor VIII
A technology of human blood coagulation factor and blood coagulation factor, which is applied in the field of medicine, can solve the problems of human albumin spreading other viruses or pathogens, decrease of coagulation factor VIII titer, and high cost of human blood albumin, so as to avoid flocculation and precipitation and improve stability Sex, the effect of maintaining protein activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0045] 1. Preparation of human coagulation factor VIII solution
[0046] (1) Making cryoprecipitate and dissolving cryoprecipitate
[0047] Use fresh frozen human plasma as raw material, melt the plasma, and centrifuge to prepare cryoprecipitate. Dissolve the cryoprecipitate with normal saline containing 8 IU / ml heparin pre-cooled at 15~20℃. The amount of saline is 7~9% of the weight of the precipitate. times, stirred and dissolved and then stood still for 60 min.
[0048] (2) Aluminum glue adsorption
[0049] Heat up the dissolved solution after standing to 25~28°C, add aluminum hydroxide gel with a mass concentration of 3% at the same temperature, the amount added is 40% of the weight of the cryoprecipitate, and add in the way of infiltration under stirring, that is, at 80~ At a stirring speed of 100 rpm, use a latex tube to pump the aluminum hydroxide gel below the liquid level of the solution at a rate of 80-100 ml / min. After the addition, cool down to 15-20°C and remove...
Embodiment 2
[0061] 1. Preparation of human coagulation factor VIII solution
[0062] Refer to step 1 of Example 1.
[0063] 2. Preparation of human coagulation factor VIII freeze-drying and dry heat treatment protective agent
[0064] Weigh various inorganic salts, amino acids and surfactants in proportion, use common medical injection water to prepare human blood coagulation factor VIII freeze-drying and dry heat treatment protective agents, and prepare human blood coagulation factor VIII freeze-drying and dry heat treatment protective agents. The original concentrations were as follows: sodium citrate 10 mmol / L, sodium chloride 100 mmol / L, calcium chloride 4 mmol / L, glycine 50 mmol / L, arginine 50 mmol / L, histidine 100 mmol / L, Lysine 100 mmol / L, Tween 80 0.1 mmol / L.
[0065] 3. The use of human coagulation factor VIII freeze-drying and dry heat treatment protective agent
[0066] Refer to step 3 of Example 1.
Embodiment 3
[0068] 1. Preparation of human coagulation factor VIII solution
[0069] Refer to step 1 of Example 1.
[0070] 2. Preparation of human coagulation factor VIII freeze-drying and dry heat treatment protective agent
[0071] Weigh various inorganic salts, amino acids and surfactants in proportion, use common medical injection water to prepare human blood coagulation factor VIII freeze-drying and dry heat treatment protective agents, and prepare human blood coagulation factor VIII freeze-drying and dry heat treatment protective agents. The original concentrations were as follows: sodium citrate 15 mmol / L, sodium chloride 50 mmol / L, calcium chloride 7 mmol / L, glycine 100 mmol / L, arginine 100 mmol / L, histidine 80 mmol / L, Lysine 80 mmol / L, Tween 80 0.2 mmol / L.
[0072] 3. The use of human coagulation factor VIII freeze-drying and dry heat treatment protective agent
[0073] Refer to step 3 of Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com